Nasdaq

Rhythm Pharmaceuticals Launches Free Genetic Testing Program for Rare Genetic Disorders of Obesity

-- Uncovering Rare Obesity program may help determine underlying cause of severe obesity ---- Program increases access to genetic testing to improve diagnosis of rare genetic disorders of obesity -- ...
Nasdaq

Rhythm Pharmaceuticals Presents New Data on Experience of People Living with Rare Genetic Diseases of Obesity and Provides Updates on Uncovering Rare Obesity® Genetic Testing ...

-- New data in patients with POMC or LEPR deficiency obesity show setmelanotide led to clinically meaningful improvements in health related quality of life measures and hunger -- -- Updated results ...
ZDNet

AliveCor uses remote medicine to provide critical heart rhythm testing to COVID-19 patients

AliveCor, the pioneer manufacturer of mobile ECG devices, announced on Monday that it would be offering a remote diagnostic service using ECGs taken from their KardiaMobile 6L device for COVID-19 ...
The Australian

Rhythm wins NATA accreditation for ColoSTAT colorectal cancer blood test, paving way for Australian launch

Test now included in the accredited scope of Rhythm’s Parkville laboratory, enabling it to be offered as an accredited clinical test to clinicians and patients across Australia The National ...
The Australian

Rhythm opens door to Southeast Asia with geneType genetic testing deal

Rhythm Biosciences (ASX: RHY) has executed a 12-month supply and distribution deal for its geneType genetic test portfolio with UK-based Digistain, a specialist international distributor for cancer ...